Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

  • This share is currently suspended. It was suspended at a price of 33.50
  • There is currently no data for SIS

Total Voting Rights

2 Mar 2017 09:15

RNS Number : 3382Y
Science in Sport PLC
02 March 2017
 

2 March 2017

 

SCIENCE IN SPORT PLC

("SiS" or the "Company")

 

Total Voting Rights

Science in Sport plc (AIM: SIS), a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts, confirms that as at 28 February 2017, the Company had 43,375,427 ordinary shares of 10 pence each ("Ordinary Shares") in issue, with one voting right each. The Company does not hold any shares in treasury. The number of Ordinary Shares with voting rights is therefore 43,375,427.

Accordingly, these figures may be used by shareholders as a denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company, under the Disclosure and Transparency Rules.

For further information:

Science in Sport PLC

+44 (0) 20 7400 3700

Stephen Moon, CEO

Elizabeth Lake, Finance Director

 

Cenkos Securities - NOMAD and Broker

 

+44 (0) 20 7397 8900

Bobbie Hilliam

Yellow Jersey PR - Financial PR

Felicity Winkles

+44 (0) 7748 843 871

Harriet Jackson

+44 (0) 7544 275 882

Notes for editors

About Science in Sport plc

Science in Sport plc is a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts. SiS is a strong brand in the elite athlete community - in the 2016 London Olympics, 34 medal-winning athletes or teams used SiS products (compared with 24 in 2012).

A key component of this trust is the Company's approach to preventing banned substances entering its supply chain and finished products. Each year an internal review of the banned substance prevention regime takes place, and from January 2017 an upgraded system has been implemented. The enhanced regime is built on the following pillars:

· Every single batch of SIS finished product which leaves the Company's factory is screened against the 2017 World Anti-Doping Agency (WADA) list. Banned substances including steroids are tested to the level of 10 Nanograms per gram, and stimulants to 100 Nanograms per gram

· Batches (sampled at the beginning, during and end of each product batch) receive the recognised and respected Informed Sport certificate and SIS provides the documentation to athletes on request

SiS is currently the official sports nutrition supplier to professional cycling team Team Sky, USA Cycling, British Cycling and Liverpool Football Club. Sir Chris Hoy & Katarina Johnson-Thompson are official brand ambassadors and cyclist Mark Cavendish is also an elite sports consultant.

The SiS core product range includes: SiS GO, comprising energy powders, isotonic gels, energy bars and hydration tablets, SiS REGO, including protein-based recovery powders and SiS Protein, products specifically designed to contribute to athletes' lean muscle mass growth and maintenance. SiS products are sold in a range of retail channels, including specialist sport retailers, major grocers, high street retailers and e-commerce websites.

SiS was founded in 1992 and is headquartered in Hatton Garden, London. Its manufacturing facility is in Nelson, Lancashire.

SiS shares are traded on the AIM market of the London Stock Exchange under the ticker symbol SIS.

For further information, please visit www.scienceinsport.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVREAPDAESPXEEF
Date   Source Headline
8th May 202510:34 amRNSForm 8.5 (EPT/RI)
7th May 20253:04 pmRNSForm 8.3 - SCIENCE IN SPORT PLC
6th May 20257:00 amRNSPublication of Scheme Document
2nd May 20254:11 pmRNSDisclosure under Rule 2.10 of the Takeover Code
2nd May 20252:31 pmRNSForm 8.3 - Science in Sport PLC
2nd May 20259:07 amRNSForm 8 (OPD) Science in sport plc
1st May 202510:40 amRNSForm 8.5 (EPT/RI) - Science in Sport PLC
30th Apr 202511:09 amRNSForm 8.3 - Science in Sport PLC
30th Apr 20259:59 amBUSForm 8.3 - Science in Sport PLC
30th Apr 20258:53 amGNWForm 8.5 (EPT/RI) - Science in Sport plc
30th Apr 20258:11 amRNS2024 Annual Report
29th Apr 20259:38 amBUSForm 8.3 - Science in Sport PLC
28th Apr 20257:00 amRNSFinal Results
25th Apr 202512:04 pmRNSForm 8.3 - Science in Sport plc
25th Apr 20259:38 amBUSForm 8.3 - Science in Sport plc
24th Apr 20255:01 pmRNSForm 8.3 - Science in Sport plc
24th Apr 20259:45 amBUSForm 8.3 - Science in Sport PLC
24th Apr 20259:37 amPRNForm 8.3 - Science In Sport Plc
23rd Apr 20255:08 pmBUSForm 8.3 - Science in Sport Plc
23rd Apr 20255:00 pmRNSForm 8.3 – Science in Sport plc
23rd Apr 202511:11 amRNSForm 8.5 (EPT/RI)
22nd Apr 20251:46 pmRNSForm 8.3 - Science in Sport PLC
22nd Apr 20251:44 pmRNSTR-1: Notification of Major Holdings
22nd Apr 202511:58 amRNSForm 8.3 - Science in Sport PLC
22nd Apr 202510:59 amRNSForm 8.5 (EPT/RI)
22nd Apr 20258:12 amGNWForm 8.5 (EPT/RI)-Science in Sport plc
17th Apr 20253:06 pmRNSForm 8.3 - Science in Sport
17th Apr 20252:52 pmGNWForm 8.3 - [SCIENCE IN SPORT PLC - Opening Disclosure - 16 04 2025] - (CGAML)
17th Apr 20252:46 pmRNSForm 8.3 - Science in Sport PLC
17th Apr 20252:39 pmRNSRecommended Cash Acquisition
17th Apr 20252:01 pmRNSForm 8.3 - Science in Sport plc
17th Apr 202512:50 pmRNSForm 8.3 - Science in Sport Plc
17th Apr 202511:46 amRNSForm 8.3 - Science in Sport plc
17th Apr 202510:25 amRNSForm 8.5 (EPT/RI) - Replacement
17th Apr 202510:08 amRNSForm 8.3 - Science in Sport plc
17th Apr 202510:05 amRNSForm 8.5 (EPT/RI)- Science in Sport plc
17th Apr 20259:04 amGNWForm 8.5 (EPT/RI) - Science in Sport plc
16th Apr 20252:36 pmRNSPossible Offer Clarification
16th Apr 20251:49 pmRNSPossible Offer
30th Jan 20257:00 amRNSTrading Statement
21st Nov 20245:32 pmRNSNotification of major holdings
27th Sep 20247:00 amRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSNotification of Major Holdings
18th Sep 20247:00 amRNSDirector/PDMR Shareholding
16th Sep 20247:00 amRNSInterim Results
15th Aug 20248:48 amRNSReplacement: Result of Annual General Meeting
31st Jul 20245:03 pmRNSResult of Annual General Meeting
31st Jul 20244:01 pmRNSNotification of Major Holdings
31st Jul 20244:00 pmRNSReplacement: Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.